Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02689063 · ClinicalTrials.gov registry record · Phase 3
Maxigesic IV Phase 3 Bunionectomy Study
A Phase 3 study of Post Operative Pain, sponsored by AFT Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 276
- Enrollment target
- 2
- Study locations
NCT02689063 is a Phase 3 study of Post Operative Pain that has completed, run by AFT Pharmaceuticals. The registered enrollment target is 276 participants, above the 232-participant average among 56 other Post Operative Pain trials with a reported enrollment target (19% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT02689063, a Phase 3 study of Post Operative Pain, has completed, sponsored by AFT Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 276 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy
Conditions Studied
Interventions
- DRUG Placebo IV
- DRUG IV Acetaminophen
- DRUG IV Ibuprofen
- DRUG Maxigesic IV
Study Locations (2)
Maryland
- Chesapeake Reserach Group - Pasadena
Texas
- Optimal Research - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2017-09-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02689063
The ClinicalTrials.gov registry entry for NCT02689063 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 232-participant average among 56 other Post Operative Pain trials with a reported enrollment target (19% higher). The listed sponsor is AFT Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Post Operative Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebo IV is the first listed.
NCT02689063 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT02689063 about?
NCT02689063 is a clinical study titled "Maxigesic IV Phase 3 Bunionectomy Study". The purpose of the study is to determine the clinical efficacy and safety of Maxigesic IV, acetaminophen IV, Ibuprofen IV versus placebo IV for the treatment of acute postoperative pain after bunionectomy
What is the current status of trial NCT02689063?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 276 participants. The study started on 2016-10-26. Estimated completion is 2017-09-15.
What conditions does trial NCT02689063 study?
This clinical trial studies the following conditions: Post Operative Pain.
What interventions are being tested in trial NCT02689063?
The interventions under investigation include: Placebo IV (DRUG), IV Acetaminophen (DRUG), IV Ibuprofen (DRUG), Maxigesic IV (DRUG).
Who is sponsoring clinical trial NCT02689063?
This trial is sponsored by AFT Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02689063 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Operative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Methadone in TKA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Methadone in THA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy
COMPLETED · Phase 3
-
A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain
COMPLETED · Phase 3
-
Ibuprofen Extended-Release Dental Pain Study
COMPLETED · Phase 3
-
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.